We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
We are considering making Dovonex Psoriasis 50 microgram/g Ointment available to buy from pharmacies. We always want to involve the public and healthcare professionals in decisions that affect them. We want to know what you think about this change.
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
The Boots Company PLC is recalling a specific batch of Hydrocortisone 1% w/w Ointment as a precautionary measure due to retained samples showing presence of Pseudomonas aeruginosa.
Take care when using creams to treat dry skin conditions as they can easily dry onto clothing, bedding and bandages making them more flammable.
The Medicines and Healthcare products Regulatory Agency (MHRA) is advising anyone experiencing skin redness or burning sensations after they have stopped using these creams or ointments to seek advice from their health professional before using these products again.
Healthcare professionals reminded that tacrolimus may be associated with possible risk of malignancy.
Product defect recall alert for Clindacutin Ointment 10 mg/g for dogs by Dechra Regulatory B.V.
Reclassification of Dovonex Psoriasis Ointment approved by MHRA
Work out the VAT liability of goods and services supplied by health and care institutions and providers of non residential care to children.
(Sanofi-aventis) Remaining stocks of the affected batches should be quarantined and returned to the original supplier for credit – class 2 action within 48 hours. (EL (13)A/07)
Medicines and Healthcare products Regulatory Agency (MHRA) have today announced the approval of Dovonex Psoriasis 50microgram/g Ointment, which will be available through pharmacies without prescription.
Neon Healthcare Ltd is recalling the specific batch mentioned in this notification as a precautionary measure.
Seizure notice served as part of an investigation by Defra Investigation Services (DIS) at residential premises in Manchester, March 2023.
Beecham Group plc trading as GlaxoSmithKline UK is recalling specific batches of Bactroban 2% Nasal Ointment 3g and Bactroban 2% Cream 15g.
(Allergan Limited) Small number of complaints have been received about small black particles found on or around the nozzle of the tube (EL (15)A/08).
Get help to classify pharmaceutical products used to treat or prevent diseases or ailments (in humans or animals), including comparators used in clinical trials and placebos.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.